Changes related to "Methotrexate (MTX)"
This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.
22 September 2018
| m 21:43 | Breast cancer (3 changes | history) . . (+2,247) . . [Jwarner (3×)] | |
| m | 21:43 (cur | prev) . . (+223) . . Jwarner (talk | contribs) (→EC {{#subobject:8d8dbe|Regimen=1}}) | |
| m | 10:14 (cur | prev) . . (+1,007) . . Jwarner (talk | contribs) (→Doxorubicin monotherapy {{#subobject:4f9e89|Regimen=1}}) | |
| m | 10:13 (cur | prev) . . (+1,017) . . Jwarner (talk | contribs) (→Doxorubicin monotherapy {{#subobject:8a2b88|Regimen=1}}) |
| m 19:33 | Prostate cancer (diff | hist) . . (+10,784) . . Jwarner (talk | contribs) |
21 September 2018
| m 20:47 | Breast cancer (2 changes | history) . . (+3,307) . . [Jwarner (2×)] | |
| m | 20:47 (cur | prev) . . (+1,199) . . Jwarner (talk | contribs) (→FEC {{#subobject:ed96e7|Regimen=1}}) | |
| m | 14:46 (cur | prev) . . (+2,108) . . Jwarner (talk | contribs) (→ddFEC {{#subobject:45dbc1|Regimen=1}}) |
20 September 2018
| m 16:58 | Breast cancer (2 changes | history) . . (+1,470) . . [Jwarner (2×)] | |
| m | 16:58 (cur | prev) . . (+1,194) . . Jwarner (talk | contribs) | |
| m | 16:29 (cur | prev) . . (+276) . . Jwarner (talk | contribs) (→St Gallen Breast Guidelines) |
18 September 2018
| m 16:57 | B-cell acute lymphoblastic leukemia (diff | hist) . . (+2,320) . . Jwarner (talk | contribs) (→Daunorubicin, L-Asparaginase, Vincristine, Prednisone {{#subobject:3c9897|Regimen=1}}) |
17 September 2018
| m 22:51 | Prostate cancer (diff | hist) . . (0) . . Jwarner (talk | contribs) (→Apalutamide monotherapy {{#subobject:a70eae |Regimen=1}}) |
| m 22:14 | Diffuse large B-cell lymphoma (diff | hist) . . (+4) . . Warner-admin (talk | contribs) (Text replacement - "'''Subset analysis:'''" to "'''Subgroup analysis:'''") |
16 September 2018
| m 20:11 | Head and neck cancer (5 changes | history) . . (+3,020) . . [Jwarner (5×)] | |
| m | 20:11 (cur | prev) . . (+2,169) . . Jwarner (talk | contribs) (→Radiation therapy {{#subobject:5ac377|Regimen=1}}) | |
| m | 20:07 (cur | prev) . . (+121) . . Jwarner (talk | contribs) (→Fluorouracil & RT {{#subobject:3a644e|Regimen=1}}) | |
| m | 20:01 (cur | prev) . . (+452) . . Jwarner (talk | contribs) (→Fluorouracil & RT {{#subobject:3a644e|Regimen=1}}) | |
| m | 19:48 (cur | prev) . . (+43) . . Jwarner (talk | contribs) (→Variant #4, 100/5000 x 4 {{#subobject:23fcf5|Variant=1}}) | |
| m | 19:35 (cur | prev) . . (+235) . . Jwarner (talk | contribs) |
| m 16:22 | Small cell lung cancer (diff | hist) . . (+1,200) . . Jwarner (talk | contribs) (→ACE {{#subobject:9fbf31|Regimen=1}}) |
| m 12:55 | Penile cancer (diff | hist) . . (0) . . Jwarner (talk | contribs) |
| 12:53 | Prostate cancer (2 changes | history) . . (+1,813) . . [Jwarner; PeterYang] | |
| m | 12:53 (cur | prev) . . (-1) . . Jwarner (talk | contribs) (→References) | |
| 12:10 (cur | prev) . . (+1,814) . . PeterYang (talk | contribs) (added apalutamide) |
| m 12:40 | Breast cancer (diff | hist) . . (+1,267) . . Jwarner (talk | contribs) (→Variant #16, 1200/50/1200 x 6 {{#subobject:d46835|Variant=1}}) |
| m 12:34 | Bladder cancer (2 changes | history) . . (+33) . . [Jwarner (2×)] | |
| m | 12:34 (cur | prev) . . (+17) . . Jwarner (talk | contribs) | |
| m | 12:31 (cur | prev) . . (+16) . . Jwarner (talk | contribs) (→References) |
| m 11:28 | CNS lymphoma (diff | hist) . . (+63) . . PeterYang (talk | contribs) (→CYVE {{#subobject:b2c919|Regimen=1}}: correction of etoposide dose) |
| m 09:27 | Acute promyelocytic leukemia (3 changes | history) . . (-203) . . [Jwarner (3×)] | |
| m | 09:27 (cur | prev) . . (-1,344) . . Jwarner (talk | contribs) (→References) | |
| m | 08:53 (cur | prev) . . (+968) . . Jwarner (talk | contribs) (→ATRA, Mercaptopurine, Methotrexate {{#subobject:b44ab6|Regimen=1}}) | |
| m | 08:07 (cur | prev) . . (+173) . . Jwarner (talk | contribs) |
